Baillie Gifford & Co
TMDX icon

Baillie Gifford & Co’s Transmedics TMDX Stock Holding History

Baillie Gifford & Co’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Sell
267,935
-37,259
-12% -$3.15M 0.02% 186
2026
Q1 		$30.3M Sell
305,194
-11,279
-4% -$1.47M 0.03% 164
2025
Q4 		$38.5M Buy
316,473
+55,754
+21% +$7M 0.03% 161
2025
Q3 		$29.3M Sell
260,719
-2,242
-0.9% -$262K 0.02% 175
2025
Q2 		$35.2M Buy
262,961
+3,284
+1% +$361K 0.03% 166
2025
Q1 		$17.5M Sell
259,677
-10,159
-4% -$699K 0.02% 186
2024
Q4 		$16.8M Buy
269,836
+34,947
+15% +$3.25M 0.01% 189
2024
Q3 		$36.9M Sell
234,889
-22,577
-9% -$3.48M 0.03% 154
2024
Q2 		$38.8M Sell
257,466
-45,696
-15% -$5.48M 0.03% 153
2024
Q1 		$22.4M Sell
303,162
-5,816
-2% -$479K 0.02% 185
2023
Q4 		$24.4M Sell
308,978
-29,184
-9% -$1.76M 0.02% 182
2023
Q3 		$18.5M Buy
338,162
+96,609
+40% +$6.95M 0.02% 187
2023
Q2 		$20.3M Sell
241,553
-11,419
-5% -$874K 0.02% 181
2023
Q1 		$19.2M Sell
252,972
-347
-0.1% -$24K 0.02% 185
2022
Q4 		$15.6M Buy
253,319
+218,048
+618% +$11.6M 0.02% 195
2022
Q3 		$1.47M Buy
35,271
+1,544
+5% +$67.1K ﹤0.01% 264
2022
Q2 		$1.06M Sell
33,727
-1,452
-4% -$38.7K ﹤0.01% 272
2022
Q1 		$948K Buy
35,179
+6,208
+21% +$111K ﹤0.01% 276
2021
Q4 		$555K Buy
28,971
+27,749
+2,271% +$696K ﹤0.01% 287
2021
Q3 		$40K Buy
1,222
+822
+206% +$25.1K ﹤0.01% 301
2021
Q2 		$13K Hold
400
– – ﹤0.01% 411
2021
Q1 		$17K Buy
+400
New +$12.3K ﹤0.01% 355

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Baillie Gifford & Co's TMDX Position: Q2 2026 in Review

Baillie Gifford & Co reduced its Transmedics (TMDX) stake by 12% in Q2 2026, selling an estimated $3.15M and leaving 267,935 shares worth $17.8M. The position accounts for 0.02% of the portfolio, ranked #186.

Baillie Gifford & Co first reported a position in TMDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $38.8M in Q2 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Baillie Gifford & Co held 267,935 shares of Transmedics worth $17.8M as of Q2 2026.
  • Baillie Gifford & Co sold 37,259 Transmedics shares in Q2 2026, an estimated $3.15M.
  • Transmedics made up 0.02% of Baillie Gifford & Co's portfolio in Q2 2026, its #186 holding.
  • Baillie Gifford & Co first reported a position in Transmedics in Q1 2021 and has held it in 22 quarters since.
  • Baillie Gifford & Co's Transmedics position peaked at $38.8M in Q2 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.